Executive Development Programme in Pharma Ethics for the C-Suite
-- ViewingNowThe Executive Development Programme in Pharma Ethics for the C-Suite is a certificate course designed to empower senior executives with a deep understanding of pharmaceutical ethics. In an industry where ethical conduct is paramount, this program provides crucial training in navigating complex ethical scenarios, ensuring regulatory compliance, and fostering a culture of integrity.
3,306+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ใใฎใณใผในใซใคใใฆ
100%ใชใณใฉใคใณ
ใฉใใใใงใๅญฆ็ฟ
ๅ ฑๆๅฏ่ฝใช่จผๆๆธ
LinkedInใใญใใฃใผใซใซ่ฟฝๅ
ๅฎไบใพใง2ใถๆ
้ฑ2-3ๆ้
ใใคใงใ้ๅง
ๅพ ๆฉๆ้ใชใ
ใณใผใน่ฉณ็ดฐ
โข
Pharma Ethical Leadership: This unit covers the importance of ethical leadership in the pharmaceutical industry and how C-Suite executives can promote a culture of ethics within their organizations.
โข
Compliance with Pharma Regulations: This unit focuses on the various regulations that govern the pharmaceutical industry, including the FDA, EMA, and MHRA, and the importance of compliance for C-Suite executives.
โข
Pharma Ethical Marketing Practices: This unit discusses the ethical considerations in pharmaceutical marketing, including the promotion of off-label use, and how C-Suite executives can ensure their marketing teams are following ethical guidelines.
โข
Pharma Clinical Trials and Ethics: This unit covers the ethical considerations in clinical trials, including informed consent, data integrity, and patient safety, and how C-Suite executives can ensure their clinical trials are conducted ethically.
โข
Pharma Pricing and Accessibility: This unit explores the ethical implications of pharmaceutical pricing, including the impact on patients and healthcare systems, and how C-Suite executives can develop pricing strategies that balance profitability with accessibility.
โข
Pharma Lobbying and Political Contributions: This unit examines the ethical considerations surrounding pharmaceutical lobbying and political contributions, and how C-Suite executives can ensure their companies are engaging in these activities ethically and transparently.
โข
Pharma Intellectual Property and Patent Ethics: This unit discusses the ethical considerations around pharmaceutical intellectual property and patents, including issues related to evergreening and access to generic drugs, and how C-Suite executives can ensure their companies are handling these matters ethically.
โข
Pharma Whistleblower Protections and Reporting Mechanisms: This unit covers the importance of protecting whistleblowers and providing reporting mechanisms for ethical concerns, and how C-Suite executives can ensure their companies have robust systems in place to encourage reporting and prevent retaliation.
โข
Pharma Supply
ใญใฃใชใขใใน
ๅ ฅๅญฆ่ฆไปถ
- ไธป้กใฎๅบๆฌ็ใช็่งฃ
- ่ฑ่ชใฎ็ฟ็ๅบฆ
- ใณใณใใฅใผใฟใผใจใคใณใฟใผใใใใขใฏใปใน
- ๅบๆฌ็ใชใณใณใใฅใผใฟใผในใญใซ
- ใณใผในๅฎไบใธใฎ็ฎ่บซ
ไบๅใฎๆญฃๅผใช่ณๆ ผใฏไธ่ฆใใขใฏใปใทใใชใใฃใฎใใใซ่จญ่จใใใใณใผในใ
ใณใผใน็ถๆณ
ใใฎใณใผในใฏใใญใฃใชใข้็บใฎใใใฎๅฎ็จ็ใช็ฅ่ญใจในใญใซใๆไพใใพใใใใใฏ๏ผ
- ่ชๅฏใใใๆฉ้ขใซใใฃใฆ่ชๅฎใใใฆใใชใ
- ่ชๅฏใใใๆฉ้ขใซใใฃใฆ่ฆๅถใใใฆใใชใ
- ๆญฃๅผใช่ณๆ ผใฎ่ฃๅฎ
ใณใผในใๆญฃๅธธใซๅฎไบใใใจใไฟฎไบ่จผๆๆธใๅใๅใใพใใ
ใชใไบบใ ใใญใฃใชใขใฎใใใซ็งใใกใ้ธใถใฎใ
ใฌใใฅใผใ่ชญใฟ่พผใฟไธญ...
ใใใใ่ณชๅ
ใณใผในๆ้
- ้ฑ3-4ๆ้
- ๆฉๆ่จผๆๆธ้ ้
- ใชใผใใณ็ป้ฒ - ใใคใงใ้ๅง
- ้ฑ2-3ๆ้
- ้ๅธธใฎ่จผๆๆธ้ ้
- ใชใผใใณ็ป้ฒ - ใใคใงใ้ๅง
- ใใซใณใผในใขใฏใปใน
- ใใธใฟใซ่จผๆๆธ
- ใณใผในๆๆ
ใณใผในๆ ๅ ฑใๅๅพ
ไผ็คพใจใใฆๆฏๆใ
ใใฎใณใผในใฎๆฏๆใใฎใใใซไผ็คพ็จใฎ่ซๆฑๆธใใชใฏใจในใใใฆใใ ใใใ
่ซๆฑๆธใงๆฏๆใใญใฃใชใข่จผๆๆธใๅๅพ
